北方長龍(301357.SZ):已向軍用複合材料運輸方艙、數據方艙等領域拓展
格隆匯10月18日丨北方長龍(301357.SZ)於近日接受特定對象調研,就“請介紹公司的產品及其優勢?”,公司回覆稱,公司主要從事以非金屬複合材料的性能研究、工藝結構設計和應用技術為核心的軍用車輛配套裝備的研發、設計、生產和銷售業務,產品廣泛應用於電子信息、裝甲戰鬥、裝甲保障等輪式、履帶車輛主戰裝備。公司發揮複合材料產品重量輕、強度高、耐腐蝕、耐老化、可設計性強等優勢,有效提升軍用車輛的機動性、安全性、使用可靠性和環境適應性。公司目前主要產品按照應用場景劃分為軍用車輛人機環系統內飾、彈藥裝備、軍用車輛輔助裝備、軍用車輛通信裝備。此外,公司已向軍用複合材料運輸方艙、數據方艙等領域拓展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.